EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A case series study of fever-diarrhea-hematochezia triad as the first presentation in plasma EBV DNA-positive diseases

Huipeng Zhang, Xiaojun Song, Ying Liu, Huijun Chang, Xia Xu, Yanbo Yu, Yan Zhang

Frontiers in Cellular and Infection Microbiology · 12.08.2026 · 16

DOI: 10.3389/fcimb.2026.1916422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 12.08.2026. Verfasst von Huipeng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human, DNA, Viral, Diarrhea. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To characterize the clinical spectrum and outcomes of fever-diarrhea-hematochezia triad as the first presentation in plasma EBV DNA-positive diseases (EBV-FDH).

Methods

This retrospective case series study was conducted at Qilu Hospital of Shandong University. We identified patients aged ≥14 years presenting with the triad of fever (>38 °C), diarrhea (≥3 loose stools/day), and hematochezia, accompanied by plasma EBV DNA positivity (≥500 copies/mL). All cases underwent a standardized diagnostic protocol including comprehensive laboratory tests, imaging, endoscopic and histopathological evaluation. Final diagnoses were established through multidisciplinary consensus.

Results

The cohort (mean age 46.5 years; 71.4% male) frequently had immune abnormalities (50%). Lymphadenopathy (78.6%) and weight loss (50%) were common. Laboratory examinations revealed universal hypocholesterolemia, with reduced ApoB and elevated Lp(a)​ further characterizing the lipid-metabolic disturbance. Endoscopy revealed widespread ulcers. Diagnoses included CAEBV, ENKTL, IBD, etc. Misdiagnosis occurred in 57.1% of cases. Treatments varied (corticosteroids, chemotherapy, surgery). Treatment strategies were heterogeneous. Despite high overall mortality (64.3%), five patients achieved long-term survival, including one who received intensive therapies such as hematopoietic stem cell transplantation and combination chemotherapy, suggesting a potential benefit of aggressive intervention in selected cases.

Conclusions

EBV-FDH is a severe syndrome with high mortality, often misdiagnosed initially. A high clinical suspicion and multimodal evaluation are crucial. Aggressive treatment, including surgery and HSCT, can enable survival in select patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsHerpesvirus 4, HumanDNA, ViralDiarrheaFeverGastrointestinal HemorrhageHumansRetrospective StudiesMiddle AgedMaleFemaleAdultYoung AdultAgedChina

Stichwörter der Autor:innen

EBER-ISHEpstein-Barr virusdifferential diagnosisfever-diarrhea-hematochezia triadlipid metabolism

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.

Zitieren

APA

Zhang, H., Song, X., Liu, Y., Chang, H., Xu, X., Yu, Y., & Zhang, Y. (2026). A case series study of fever-diarrhea-hematochezia triad as the first presentation in plasma EBV DNA-positive diseases. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1916422

Vancouver

Zhang H, Song X, Liu Y, Chang H, Xu X, Yu Y, et al. A case series study of fever-diarrhea-hematochezia triad as the first presentation in plasma EBV DNA-positive diseases. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1916422

BibTeX
@article{Zhang2026,
  author = {Zhang, Huipeng and Song, Xiaojun and Liu, Ying and Chang, Huijun and Xu, Xia and Yu, Yanbo and Zhang, Yan},
  title = {A case series study of fever-diarrhea-hematochezia triad as the first presentation in plasma EBV DNA-positive diseases},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1916422}
}
Kostenlos starten →